During the past decade, AccumetRx Clinical Research - Division of Urology Group of New Mexico conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AccumetRx Clinical Research - Division of Urology Group of New Mexico" are "Overactive Bladder" (2 trials). Many other conditions were trialed in "AccumetRx Clinical Research - Division of Urology Group of New Mexico" in a lesser frequency.

Most popular intervention types in "AccumetRx Clinical Research - Division of Urology Group of New Mexico" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Tolterodine Tartrate ER" (2 trials), "Tolterodine placebo" (1 trials), "Vibegron" (1 trials), "Vibegron placebo" (1 trials) and "placebos" (1 trials). Other intervention names were less common.

The vast majority of trials in "AccumetRx Clinical Research - Division of Urology Group of New Mexico" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AccumetRx Clinical Research - Division of Urology Group of New Mexico". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in AccumetRx Clinical Research - Division of Urology Group of New Mexico, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AccumetRx Clinical Research - Division of Urology Group of New Mexico, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".